Table 2 Treatment and patient related parameters
Mean age (years) | 69 (range: 45-92) |
RT prescription dose | 13 × 3.2 = 41.6 Gy |
RT boost doses | |
no boost | 1 |
1 × 3 = 3 Gy | 1 |
3 × 3 = 9 Gy | 65 |
4 × 3 = 12 Gy | 23 |
5 × 2 = 10 Gy | 2 |
8 × 2 = 16 Gy | 2 |
10 × 2 = 20 Gy | 4 |
RT periclavicular lymphatics | |
N-status | 3 |
N0 | 71 |
N1 | 25 |
N2 | 1 |
N3 | 1 |
T-status | |
DCIS | 3 |
T1 | 56 |
T2 | 39 |
T3 | 0 |
T4 | 0 |
Grading | |
G1 | 16 |
G2 | 45 |
G3 | 33 |
Not known | 4 |
R0 | 11 |
R1 | 87 |
Hormone receptor | |
Positive | 85 |
Negative | 12 |
Not known | 1 |
Her2 status | |
Positive | 10 |
Negative | 86 |
Not known | 2 |
Chemotherapy | 23 |